Pancreatitis, Chronic: Clinical Trials

16 trials for Pancreatitis, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 16 Phase 2, 6 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 16
Phase 16Completed 6
Phase 31Completed 1

Follow Pancreatitis, Chronic: new trials by email Literature Review of Pancreatitis, Chronic trials Research Report on Pancreatitis, Chronic

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis
Lidocaine IV - Pancreatic Cancer, Chronic Pancreatitis
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)302021-01-142023-10-02
Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis
Spinal Cord Stimulation, Sham - Chronic Pancreatitis, Chronic Pain
Phase 2CompletedAalborg University Hospital162020-11-012024-01-30
Trial of Indomethacin in Chronic Pancreatitis
Indomethacin, Placebo, Endoscopy for Pancreatic Function Testing - Chronic Pancreatitis
Phase 1 / Phase 2CompletedMayo Clinic272020-07-152024-09-04
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT
Hydroxychloroquine, Placebo - Chronic Pancreatitis, Insulin Dependent Diabetes
Phase 2CompletedThe Cleveland Clinic92017-10-032022-04-08
A Phase IIa Study With Escalating Dose of MS1819-SD
MS1819-SD - Chronic Pancreatitis, Distal Pancreatectomy
Phase 2CompletedAzurRx SAS112017-01-272018-09-28
Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
Prolastin-C, Placebo - Chronic Pancreatitis
Phase 1 / Phase 2CompletedMedical University of South Carolina482017-01-112023-06-29
Fat Malabsorption in Chronic Pancreatitis
Creon36™ - Chronic Pancreatitis
Phase 2CompletedChildren's Hospital of Philadelphia482016-10-132019-05-03
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
NI-03, Placebo - Chronic Pancreatitis
Phase 1 / Phase 2CompletedKangen Pharmaceuticals, Inc2642016-02-242022-12-16
Carbon Monoxide-Saturated Medium for Islet Isolation
Carbon monoxide-bubbled mediums - Chronic Pancreatitis
Phase 1 / Phase 2CompletedMedical University of South Carolina162015-01-012019-01-04
Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain
Tetrahydrocannabinol, Placebo - Pancreatitis, Chronic, Abdominal Pain
Phase 2CompletedRadboud University Medical Center292012-10-012014-10-28
Rituximab in IgG4-RD: A Phase 1-2 Trial
Rituximab - Retroperitoneal Fibrosis, Autoimmune Pancreatitis
Phase 1 / Phase 2CompletedMassachusetts General Hospital302012-04-012017-07-02
Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain
Namisol, Diazepam - Cannabinoid, Tetrahydrocannabinol
Phase 2CompletedRadboud University Medical Center242011-10-012013-07-09
Secretin Infusion for Pain Due to Chronic Pancreatitis
Human Secretin - Chronic Pancreatitis
Phase 1 / Phase 2CompletedChiRhoClin, Inc.122010-12-012016-03-09
BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency
benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala) - Chronic Pancreatitis, Healthy Volunteers
Phase 2CompletedMeridian Bioscience, Inc.332009-01-012022-12-20
Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality
Pioglitazone, Placebo - Chronic Pancreatitis, Insulin Resistance
Phase 2CompletedUniversity of Michigan642008-11-012018-01-11
Pain and Chronic Pancreatitis - Clinical End Experimental Studies
Pregabalin, placebo - Chronic Pancreatitis
Phase 2 / Phase 3CompletedAalborg University Hospital642008-10-012010-08-20

Narrower conditions

Abdominal Pain (2)  ·  Chronic Pain (2)  ·  Exocrine Pancreatic Insufficiency (2)  ·  Pain (2)  ·  Pancreatitis (2)  ·  Autoimmune Pancreatitis (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Insulin Resistance (1)  ·  Lymphadenopathy (1)  ·  Meningitis (1)  ·  Neuralgia (1)  ·  Orbital Pseudotumor (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Chronic Disease (16)  ·  Digestive System Diseases (16)  ·  Disease Attributes (16)  ·  Pancreatic Diseases (16)  ·  Pathologic Processes (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Pancreatitis (14)  ·  Neurologic Manifestations (4)  ·  Signs and Symptoms (4)  ·  Autoimmune Diseases (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Immune System Diseases (2)  ·  Metabolic Diseases (2)  ·  Nervous System Diseases (2)

Interventions

Dronabinol (2)  ·  Diazepam (1)  ·  Endoscopy (1)  ·  Hydroxychloroquine (1)  ·  Indomethacin (1)  ·  Pancrelipase (1)  ·  Pioglitazone (1)  ·  Pregabalin (1)  ·  Rituximab (1)  ·  Secretin (1)  ·  Sodium Chloride (1)  ·  Spinal Cord Stimulation (1)  ·  benzoyl-tyrosyl-alanine (1)

Sponsors

Aalborg University Hospital (2)  ·  Medical University of South Carolina (2)  ·  Radboud University Medical Center (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  AzurRx SAS (1)  ·  ChiRhoClin, Inc. (1)  ·  Children's Hospital of Philadelphia (1)  ·  Kangen Pharmaceuticals, Inc (1)  ·  Massachusetts General Hospital (1)  ·  Mayo Clinic (1)  ·  Meridian Bioscience, Inc. (1)  ·  The Cleveland Clinic (1)  ·  University of Michigan (1)

Countries

United States (8)  ·  Netherlands (4)  ·  Denmark (2)  ·  Australia (1)  ·  France (1)  ·  India (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Ukraine (1)

Top investigators

Harry van Goor, MD PhD (2)  ·  Hongjun Wang, Ph.D (2)  ·  Arezou Khosroshahi, MD (1)  ·  Babette Zemel, PhD (1)  ·  Betul Hatipoglu, MD (1)  ·  Helga A Gulisano, MD (1)  ·  John H Stone, MD, MPH (1)  ·  Marc G. Besselink, MD PhD MSc (1)  ·  Matthew DiMagno, M.D. (1)  ·  Phiip Hart, MD (1)  ·  Santhi Vege, MD (1)  ·  Timothy B Gardner, M.D. (1)  ·  Virginia Stallings, MD (1)

Results publications

PMID 21848870, PMID 22879908, PMID 23548879, PMID 25667206, PMID 27720917, PMID 31412955, PMID 38103842, PMID 38659255, PMID 40622408

NIH funding

R01DK105183 (1), R21AA017271 (1), R21DK117212 (1)